Alpha-9 Oncology
Company Information
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company based in Vancouver. The company develops targeted molecules for precision cancer therapy and describes its approach as optimizing each component of the radiopharmaceutical molecule, including the binder, linker, chelator, and radioisotope. Alpha-9 positions itself squarely in precision oncology with in-house formulation expertise and purpose-built radiopharmaceutical infrastructure.
Industry Focus and Technologies
Radiopharmaceuticals, precision oncology, targeted cancer therapeutics, molecular design, and clinical-stage oncology development.
Location
Vancouver, British Columbia, Canada
Company Size and Stage
Products, Platforms or Focus Areas
Clinical-stage radiopharmaceutical pipeline; targeted cancer molecules; and a design platform focused on binder, linker, chelator, and radioisotope optimization.